Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Quick Stats
Jan 30, 202652.5
AI Score
HOLD0.21
Volume Ratio
Mar 17, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
PYXS Stock Summary
Last updated Jan 30, 2026
PYXS is currently trading at $1.45, positioned below its 200-day moving average of $2.05, suggesting bearish momentum. The stock has a 52-week range of $0.8332 to $5.55.
Technical Analysis: The 50-day moving average stands at $2.75, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.454, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.131, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates PYXS at 52.5/100 with a HOLD recommendation.
PYXS (Pyxis Oncology, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.454 |
| CMF (20) | 0.131 |
| ROC (10) | -21.196 |
| ADX (14) | 25.285 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.236 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -97.279 |
| MFI (14) | 50.133 |
PYXS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PYXS Price vs Max Options Open Interest
PYXS Max Change In Options Open Interest
PYXS Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PYXS Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PYXS Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PYXS Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Pyxis Oncology, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PYXS Moving Averages Analysis
PYXS (Pyxis Oncology, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.62 |
| 20 | 1.61 |
| 30 | 1.55 |
| 50 | 2.75 |
| 100 | 2.91 |
| 200 | 2.05 |
PYXS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 94.0 million |
| Earnings/Share ($) | -1.58 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.3111 |
| EPS Estimate Next Year ($) | -1.1838 |
| WallStreet Target Price ($) | 7.175 |
| Most Recent Quarter |